Rosemary Zhang

670 citations
10 papers · 382 indexed · h-index 8
Topics
Melanoma and MAPK Pathways (7 papers)Computational Drug Discovery Methods (4 papers)Synthesis and biological activity (3 papers)

In The Last Decade

Rosemary Zhang

10 papers receiving 378 citations

Peers

Rosemary Zhang
Comparison fields: 5 of 62
  • Molecular Biology 110
  • Hematology 104
  • Organic Chemistry 98
  • Oncology 98
  • Immunology 83
Replace Karen Froning with:
Karen Froning United States
Jonathan S. George United States
Federico Rossari Italy
Christopher Weier United States
Thomas G. Gesner United States
Ami Miller United Kingdom
Bo‐Tao Xin Netherlands
Latha Sridharan United States
Marcelo J. Murai United States
Kehinde Adekola United States
Rosemary Zhang relative to Karen Froning United States Karen Froning's profile →
Citations per field
00.5×1.5×2.3×
Karen Froning · 1×
Citations per year

Countries citing papers authored by Rosemary Zhang

Since Specialization
Citations

This map shows the geographic impact of Rosemary Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosemary Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosemary Zhang more than expected).

Fields of papers citing papers by Rosemary Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosemary Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosemary Zhang. The network helps show where Rosemary Zhang may publish in the future.

Co-authorship network of co-authors of Rosemary Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Rosemary Zhang. A scholar is included among the top collaborators of Rosemary Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosemary Zhang. Rosemary Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 6
2 15
3 9
4 26
5 19
6 2
7 25
8 37
9 221
10 22

About Rosemary Zhang

Rosemary Zhang is a scholar working on Computational Theory and Mathematics, Organic Chemistry and Hematology, having authored 10 papers that have together received 382 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (7 papers), Computational Drug Discovery Methods (4 papers) and Synthesis and biological activity (3 papers). The work is most often cited by research in Hematology (104 citations), Genetics (81 citations) and Immunology (83 citations). Rosemary Zhang has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Gary L. Schieven, Anna Jankowska, Jaroslaw P. Maciejewski, Vojkan Susulic, Robert Townsend, Hadrian Szpurka, Andrew E. Schade, Arthur M. Doweyko, Joel C. Barrish and Sidney Pitt. Their work appears in journals such as Blood, The Journal of Immunology and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026